Vimarsana
Biggest News Aggregation in the World

About Iadademstat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from About Iadademstat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In About Iadademstat Today - Breaking & Trending Today

Oryzon Genomics S A : to provide corporate progress updates at several events in June - Vimarsana News

Oryzon Genomics S A : to provide corporate progress updates at several events in June

30 May 2024 ORYZON to provide corporate progress updates at several events in June BIO International Convention 2024 ...

Oryzon Genomics S A : to provide corporate progress updates at several events in April -April 05, 2024 at 02:17 am EDT - Vimarsana News

Oryzon Genomics S A : to provide corporate progress updates at several events in April -April 05, 2024 at 02:17 am EDT

5 April 2024 ORYZON to provide corporate progress updates at several events in April Investing in Oncology Forum 2024 ...

Oryzon Genomics S A : reports financial results and corporate updates for half-year ending June 30, 2023 - Vimarsana News

Oryzon Genomics S A : reports financial results and corporate updates for half-year ending June 30, 2023

24 July 2023 ORYZON reports financial results and corporate updates for half-year ending June 30, 2023 Positive aggregate safety data from...

Oryzon Genomics S A : Announces Voting Results from its 2023 Annual General Meeting of Shareholders - Vimarsana News

Oryzon Genomics S A : Announces Voting Results from its 2023 Annual General Meeting of Shareholders

27 June 2023 ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders All resolutions were approved. 35% of the issued shares represented. ...

Oryzon Genomics S A : announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas - Vimarsana News

Oryzon Genomics S A : announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas

18 January 2023 ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas ... | January 18, 2023